ConductScience.org, home

Paper41219657

Cognitive control as a transdiagnostic mechanism of action in psychedelic effects.

Sayalı C and 3 others. Cogn Affect Behav Neurosci, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Cognitive control as a transdiagnostic mechanism of action in psychedelic effects. Papers, record 41219657. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41219657

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cognitive control as a transdiagnostic mechanism of action in psychedelic effects.
PubMed
Journal
Cogn Affect Behav Neurosci
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sayalı CCeyda
2Truesdale AAllie
3Rosen DSDavid S
4Barrett FSFrederick S

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References92

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117719799A default mode of brain function: a brief history of an evolving idea.Neuroimage2007https://conductscience.org/library/papers/17719799PubMed
221956447Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers.Neuropsychopharmacology2012https://conductscience.org/library/papers/21956447PubMed
338319885Multiplexed Levels of Cognitive Control through Delta and Theta Neural Oscillations.J Cogn Neurosci2024https://conductscience.org/library/papers/38319885PubMed
411283309An integrative theory of prefrontal cortex function.Annu Rev Neurosci2001https://conductscience.org/library/papers/11283309PubMed
527441452Long-term follow-up of psilocybin-facilitated smoking cessation.Am J Drug Alcohol Abuse2017https://conductscience.org/library/papers/27441452PubMed
635166158Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.J Psychopharmacol2022https://conductscience.org/library/papers/35166158PubMed
736807609Acute psilocybin enhances cognitive flexibility in rats.Neuropsychopharmacology2023https://conductscience.org/library/papers/36807609PubMed
81948051Functional mapping of the human visual cortex by magnetic resonance imaging.Science1991https://conductscience.org/library/papers/1948051PubMed
931941394Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.J Psychopharmacol2020https://conductscience.org/library/papers/31941394PubMed
1030062577Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition.Psychopharmacology (Berl)2018https://conductscience.org/library/papers/30062577PubMed
1115305143Psilocybin impairs high-level but not low-level motion perception.Neuroreport2004https://conductscience.org/library/papers/15305143PubMed
1232042038Emotions and brain function are altered up to one month after a single high dose of psilocybin.Sci Rep2020https://conductscience.org/library/papers/32042038PubMed
1336801369Task fMRI paradigms may capture more behaviorally relevant information than resting-state functional connectivity.Neuroimage2023https://conductscience.org/library/papers/36801369PubMed
1434897383Models of psychedelic drug action: modulation of cortical-subcortical circuits.Brain2022https://conductscience.org/library/papers/34897383PubMed
1528940312Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations.Acta Psychiatr Scand2017https://conductscience.org/library/papers/28940312PubMed
1633567945Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings.J Psychopharmacol2021https://conductscience.org/library/papers/33567945PubMed
1716123739Inhibition of return in the human 5HT2A agonist and NMDA antagonist model of psychosis.Neuropsychopharmacology2006https://conductscience.org/library/papers/16123739PubMed
1830692255Effective connectivity changes in LSD-induced altered states of consciousness in humans.Proc Natl Acad Sci U S A2019https://conductscience.org/library/papers/30692255PubMed
1931082635Frontal theta activity and white matter plasticity following mindfulness meditation.Curr Opin Psychol2019https://conductscience.org/library/papers/31082635PubMed
2025352153Predicting brain states associated with object categories from fMRI data.J Integr Neurosci2014https://conductscience.org/library/papers/25352153PubMed

See all 92 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn Papers
42775190Mystical but not challenging experiences predict symptom improvement after psilocybin for treatment-resistant OCD.Front Psychiatry2026https://conductscience.org/library/papers/42775190

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41219657

GET https://conductscience.org/api/papers/v1/41219657/references?page=2